In addition to our highly qualified and experienced team, our Scientific Board comprises a group of clinical KOLs and specialized Industry Experts.
The input and advice from our Scientific Board members from specific clinical practice and industry perspectives will support paving the way towards integrating the research concept of the project into daily clinical practice.
Prof. Dr. Lazar Popovic, MD, PhD
Professor of Oncology, Faculty of Medicine, University of Novi Sad
Dr. Lazar Popovic is a Professor of Oncology, experienced researcher and practicing Oncologist. His research activities include investigating Breast cancer, Head and Neck cancer, Urological malignancies, and Lymphoma. Dr. Popovic is an experienced clinical investigator and has contributed to more than 14 Oncology studies in all clinical phases as either Principal Investigator or Sub-investigator. He has authored 80 scientific publications and co-authored six scientific books in the field of Oncology and Clinical Research. He is a member of various International Oncology Associations and has also served as the Editor-in-Chief for the Archive of Oncology journal.
Kevin H. McAllister, PhD, MBA
Kevin McAllister is a seasoned researcher and pharmaceutical professional with over 30 years of experience in the pharmaceutical industry. Kevin joined the preclinical nervous system research department of Sandoz and has held a variety of positions including Executive Director of Neuroscience at Novartis and Principal Medical Scientific Expert in the Neuroscience Clinical Development Franchise. Kevin is currently Managing Director of Neurenable GmbH, a company dedicated to enabling Neuroscience drug discovery and development and Chief Scientific Officer at SOM Biotech, a clinical-stage biopharmaceutical company accelerating discovery of therapies for unmet needs.
Prof. Dr. Djordje Popovic, MD, PhD
Asst. Prof. Internal Medicine, Faculty of Medicine, Univ. of Novi Sad
Dr. Djordje Popvic is an Assistant Professor of Internal Medicine, Endocrinologist and experienced researcher. His research activities include the pathogenesis of type 2 diabetes, chronic complications of diabetes, diabetes therapy, and adipose tissue biology. Dr. Popovic is an experienced clinical investigator and has contributed to more than ten clinical studies as Investigator or Sub-investigator. He has authored 33 scientific articles and is a member of the Editorial Board of four international medical journals of internal medicine and diabetes.
Thierry Cousin, MD
Dr. Thierry Cousin is a Medical Expert and pharmaceutical professional with more than 30 years of industry experience in Medical Affairs, Program Leadership and Market Access. Thierry has contributed to the development of various drugs during his tenure at Hoffmann La Roche, Servier, Pierre Fabre Institute and Aventis Pharma. He has contributed to the registration and marketing of nine major drugs with the FDA and European Medicines Agency. Dr. Thierry Cousin is currently the CMO of ECS Progastrin Thierry and also has a global vision of company needs with experience in Oncology, Hematology, Autoimmune and Infectious Diseases.